Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma. [electronic resource]
Producer: 20170213Description: 95 p. digitalISSN:- 1746-1596
- Algorithms
- Antibodies, Monoclonal -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Area Under Curve
- B7-H1 Antigen -- analysis
- Biomarkers, Tumor -- analysis
- Carcinoma, Non-Small-Cell Lung -- chemistry
- Carcinoma, Squamous Cell -- chemistry
- Cell Line, Tumor
- Fixatives
- Formaldehyde
- HEK293 Cells
- Head and Neck Neoplasms -- chemistry
- Humans
- Immunohistochemistry
- Laboratory Proficiency Testing
- Lung Neoplasms -- chemistry
- Observer Variation
- Paraffin Embedding
- Predictive Value of Tests
- ROC Curve
- Reproducibility of Results
- Squamous Cell Carcinoma of Head and Neck
- Tissue Fixation -- methods
- Transfection
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Validation Study
There are no comments on this title.
Log in to your account to post a comment.